Lupus: targeted treatment shows great promise and is already available
For the first time in systemic lupus erythematosus, ustekinumab, an interleukin 13/23 inhibitor already available in other diseases, demonstrates its ...
Read moreFor the first time in systemic lupus erythematosus, ustekinumab, an interleukin 13/23 inhibitor already available in other diseases, demonstrates its ...
Read more